Article Sidebar
Published:
Jul 12, 2023Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Salvianolic acid A regulates Nrf2 and NF-κB pathways to alleviate lipopolysaccharide-induced pneumonia cell damage
Abstract
Purpose: To examine the regulatory roles of salvianolic acid A (SA-A) in lipopolysaccharide-induced pneumonia cell damage.
Methods: Cell proliferation in lung epithelial cells BEAS-2B was determined using CCK-8 assay while cell apoptosis was assessed by flow cytometry. The levels of TNF-α, IL-1β and IL-6 were determined using enzyme-linked immunosorbent assay (ELISA). Protein expressions were evaluated using western blot, while the levels of superoxide dismutase (SOD), myeloperoxidase (MPO), and malondialdehyde (MDA) were assessed using their corresponding ELISA kits.
Results: Cell apoptosis was enhanced after LPS induction (p < 0.001), but this change was offset after SA-A treatment (p < 0.05). Inflammation was increased after LPS stimulation (p < 0.001), but this change was offset following SA-A treatment (p < 0.05). Oxidative stress was heightened after LPS induction (p < 0.05), but reversed following SA-A treatment (p < 0.05). Finally, LPS stimulation enhanced endoplasmic reticulum stress and mitochondrial dysfunction (p < 0.001), which was significantly reversed by SA-A treatment (p < 0.05).
Conclusion: SA-A regulates Nrf2 and NF-κB pathways, inhibits oxidative stress, inflammationstimulated ER stress, and mitochondrial dysfunction. It also alleviates LPS-induced pneumonia cell damage, thus indicating its potentials for development as a therapeutic agent for the treatment of pneumonia.
